Two Sigma Investments, LP Gilead Sciences, Inc. Transaction History

Two Sigma Investments, LP

  • $40.3 Billion
  • Q1 2024

A detailed history of Two Sigma Investments, LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 3,196,673 shares of GILD stock, worth $219 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
3,196,673
Previous 19,000 16724.59%
Holding current value
$219 Million
Previous $1.54 Million 15114.81%
% of portfolio
0.58%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$71.58 - $87.29 $227 Million - $277 Million
3,177,673 Added 16724.59%
3,196,673 $234 Million
Q4 2023

Feb 14, 2024
SELL
$73.27 - $83.09 $179 Million - $203 Million
-2,438,656 Reduced 99.23%
19,000 $1.54 Million
Q3 2023

Nov 14, 2023
BUY
$73.94 - $80.67 $118 Million - $129 Million
1,602,283 Added 187.32%
2,457,656 $184 Million
Q2 2023

Aug 14, 2023
SELL
$76.01 - $86.7 $115 Million - $131 Million
-1,513,653 Reduced 63.89%
855,373 $65.9 Million
Q1 2023

May 15, 2023
SELL
$77.31 - $88.08 $45.4 Million - $51.7 Million
-586,766 Reduced 19.85%
2,369,026 $197 Million
Q4 2022

Feb 14, 2023
SELL
$62.32 - $89.47 $37.7 Million - $54.1 Million
-605,147 Reduced 16.99%
2,955,792 $254 Million
Q3 2022

Nov 14, 2022
BUY
$59.54 - $68.01 $21.1 Million - $24.1 Million
355,044 Added 11.07%
3,560,939 $220 Million
Q2 2022

Aug 15, 2022
BUY
$57.72 - $65.01 $38.4 Million - $43.2 Million
664,765 Added 26.16%
3,205,895 $198 Million
Q1 2022

May 16, 2022
BUY
$57.92 - $72.58 $62.8 Million - $78.8 Million
1,085,059 Added 74.52%
2,541,130 $151 Million
Q4 2021

Feb 14, 2022
SELL
$64.88 - $73.64 $108 Million - $123 Million
-1,669,899 Reduced 53.42%
1,456,071 $106 Million
Q3 2021

Nov 15, 2021
BUY
$67.69 - $73.03 $162 Million - $175 Million
2,392,373 Added 326.12%
3,125,970 $218 Million
Q2 2021

Aug 16, 2021
BUY
$63.47 - $69.35 $36.7 Million - $40.1 Million
577,719 Added 370.62%
733,597 $50.5 Million
Q4 2020

Feb 16, 2021
BUY
$56.65 - $64.55 $6.8 Million - $7.75 Million
120,105 Added 335.74%
155,878 $9.08 Million
Q1 2020

May 15, 2020
SELL
$62.63 - $80.22 $12.4 Million - $15.8 Million
-197,232 Reduced 84.65%
35,773 $2.67 Million
Q4 2019

Feb 14, 2020
SELL
$61.62 - $67.78 $41.9 Million - $46.1 Million
-680,479 Reduced 74.49%
233,005 $15.1 Million
Q3 2019

Nov 14, 2019
SELL
$62.51 - $69.0 $97.5 Million - $108 Million
-1,560,212 Reduced 63.07%
913,484 $57.9 Million
Q2 2019

Aug 14, 2019
SELL
$61.87 - $69.38 $21.7 Million - $24.3 Million
-350,685 Reduced 12.42%
2,473,696 $167 Million
Q1 2019

May 15, 2019
BUY
$62.53 - $70.05 $59.3 Million - $66.4 Million
947,758 Added 50.5%
2,824,381 $184 Million
Q4 2018

Feb 14, 2019
BUY
$60.54 - $79.0 $75.7 Million - $98.8 Million
1,250,898 Added 199.91%
1,876,623 $117 Million
Q3 2018

Nov 14, 2018
BUY
$71.28 - $78.92 $24.5 Million - $27.1 Million
343,520 Added 121.73%
625,725 $48.3 Million
Q2 2018

Aug 14, 2018
BUY
$64.88 - $75.68 $14.8 Million - $17.3 Million
228,720 Added 427.63%
282,205 $20 Million
Q1 2018

May 15, 2018
SELL
$72.84 - $88.8 $25.9 Million - $31.6 Million
-355,720 Reduced 86.93%
53,485 $4.03 Million
Q4 2017

Feb 14, 2018
SELL
$71.15 - $83.52 $22.3 Million - $26.1 Million
-313,068 Reduced 43.34%
409,205 $29.3 Million
Q3 2017

Nov 14, 2017
BUY
$72.11 - $85.47 $52.1 Million - $61.7 Million
722,273
722,273 $58.5 Million

Others Institutions Holding GILD

# of Institutions
1,884
Shares Held
1B
Call Options Held
8.71M
Put Options Held
8.02M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $86B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email